Acute Myelogenous Leukemia

specific

A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).

60

Centers

54

Active Trials

$47M

Cancer Funding

Top Centers for Acute Myelogenous Leukemia(60)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
89.6
2
NCI Comprehensive
High-Volume Research Center
70.4
3
NCI Comprehensive
Active Research Program
69.8
4
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
69.2
5
NCI Clinical
Active Research Program
68.7
6
NCI Comprehensive
Active Research Program
68.2
7
NCI Comprehensive
Active Research Program
68.2
8
Active Research Program
68.2
9
NCI Comprehensive
Active Research Program
68.1
10
NCI Comprehensive
Active Research Program
67.5
11
NCI Comprehensive
Active Research Program
66.9
12
NCI Comprehensive
Active Research Program
63.8
1363.8
14
NCI Comprehensive
Active Research Program
63.8
15
NCI Comprehensive
Active Research Program
63.8
16
Active Research Program
63.8
17
Active Research Program
63.8
18
Active Research Program
63.8
19
Active Research Program
63.8
20
Active Research Program
63.8
21
NCI Comprehensive
Active Research Program
54.5
22
NCI Comprehensive
Active Research Program
53.4
23
NCI Comprehensive
Active Research Program
51.8
24
NCI Comprehensive
Active Research Program
51.8
25
NCI Comprehensive
Active Research Program
51.8
26
NCI Comprehensive
Active Research Program
51.8
27
NCI Comprehensive
Active Research Program
51.8
28
NCI Comprehensive
Active Research Program
51.8
29
NCI Comprehensive
Active Research Program
51.8
30
NCI Clinical
Active Research Program
51.8
31
NCI Comprehensive
Active Research Program
51.8
32
NCI Comprehensive
Active Research Program
51.8
33
NCI Comprehensive
Active Research Program
51.8
3451.8
35
Active Research Program
51.8
36
Active Research Program
51.8
37
Active Research Program
51.8
38
Active Research Program
51.8
39
NCI Clinical
Active Research Program
48.7
4034.1
41
NCI Comprehensive
34.1
4234.1
43
NCI Comprehensive
34.1
44
NCI Comprehensive
34.1
45
NCI Comprehensive
34.1
4634.1
4734.1
48
NCI Comprehensive
34.1
49
NCI Comprehensive
34.1
50
Cedars-Sinai CancerLos Angeles, CA
34.1
51
NCI Comprehensive
34.1
5234.1
5334.1
5434.1
5534.1
5634.1
5734.1
5834.1
5934.1
60
BC CancerVancouver, BC
34.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →